Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics
A Kirtonia, K Gala, SG Fernandes, G Pandya… - Seminars in cancer …, 2021 - Elsevier
Human malignancies are one of the major health-related issues though out the world and
anticipated to rise in the future. The development of novel drugs/agents requires a huge …
anticipated to rise in the future. The development of novel drugs/agents requires a huge …
Statin drugs to reduce breast cancer recurrence and mortality
Epidemiologic studies have, variably, shown the concomitant use of statin drugs to be
beneficial to cancer outcomes. Statin drugs have been FDA approved for three decades for …
beneficial to cancer outcomes. Statin drugs have been FDA approved for three decades for …
Direct activation of Bax protein for cancer therapy
Bax, a central cell death regulator, is an indispensable gateway to mitochondrial dysfunction
and a major proapoptotic member of the B‐cell lymphoma 2 (Bcl‐2) family proteins that …
and a major proapoptotic member of the B‐cell lymphoma 2 (Bcl‐2) family proteins that …
Lipophilic statins and risk for hepatocellular carcinoma and death in patients with chronic viral hepatitis: results from a nationwide Swedish population
TG Simon, AS Duberg, S Aleman… - Annals of internal …, 2019 - acpjournals.org
Background: Whether statin type influences hepatocellular carcinoma (HCC) incidence or
mortality in chronic hepatitis B or C virus infection is unknown. Objective: To assess the …
mortality in chronic hepatitis B or C virus infection is unknown. Objective: To assess the …
Examining bias in studies of statin treatment and survival in patients with cancer
L Emilsson, X García-Albéniz, RW Logan… - JAMA …, 2018 - jamanetwork.com
Importance Patients with cancer who use statins appear to have a substantially better
survival than nonusers in observational studies. However, this inverse association between …
survival than nonusers in observational studies. However, this inverse association between …
Nonalcoholic fatty liver disease, diabetes, obesity, and hepatocellular carcinoma
M Noureddin, ME Rinella - Clinics in liver disease, 2015 - liver.theclinics.com
Nonalcoholic fatty liver disease (NAFLD) is now the most common liver disease in the
United States, with more than 80 million Americans affected. It represents a spectrum of …
United States, with more than 80 million Americans affected. It represents a spectrum of …
[HTML][HTML] Cytoprotective remedies for ameliorating nephrotoxicity induced by renal oxidative stress
Aims Nephrotoxicity is the hallmark of anti-neoplastic drug metabolism that causes oxidative
stress. External chemical agents and prescription drugs release copious amounts of free …
stress. External chemical agents and prescription drugs release copious amounts of free …
Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease
B Yeganeh, E Wiechec, SR Ande, P Sharma… - Pharmacology & …, 2014 - Elsevier
The cholesterol biosynthesis pathway, also known as the mevalonate (MVA) pathway, is an
essential cellular pathway that is involved in diverse cell functions. The enzyme 3-hydroxy-3 …
essential cellular pathway that is involved in diverse cell functions. The enzyme 3-hydroxy-3 …
The effect of statins on cancer cells
L Matusewicz, J Meissner, M Toporkiewicz, AF Sikorski - Tumor Biology, 2015 - Springer
Abstract Statins [3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase,
abbreviated HMGCR) inhibitors], are well-known cholesterol-depleting agents. Since the …
abbreviated HMGCR) inhibitors], are well-known cholesterol-depleting agents. Since the …
[HTML][HTML] Tumor macroenvironment and metabolism
W Al-Zhoughbi, J Huang, GS Paramasivan, H Till… - Seminars in …, 2014 - Elsevier
In this review we introduce the concept of the tumor macroenvironment and explore it in the
context of metabolism. Tumor cells interact with the tumor microenvironment including …
context of metabolism. Tumor cells interact with the tumor microenvironment including …